<?xml version='1.0' encoding='utf-8'?>
<document id="31464786"><sentence text="Identifying characteristics of drug-related problems in critically ill patients with decompensated liver cirrhosis." /><sentence text="Characteristics of drug-related problems and related patient harm has not been evaluated in critically ill patients with decompensated cirrhosis" /><sentence text=" Our objectives were to identify characteristics and incidence rate of drug-related problems and related preventable harm in critically ill patients with decompensated liver cirrhosis" /><sentence text="" /><sentence text="A prospective observational study was conducted from February 2018 to January 2019 in 10-bed medical intensive care unit of a tertiary care hospital" /><sentence text=" Medication charts of 78 patients diagnosed with decompensated cirrhosis were reviewed by the clinical pharmacist" /><sentence text=" Pharmaceutical care-related standard tools were applied for classification of drug-related problems and their severity of outcomes" /><sentence text="" /><sentence text="A total of 394 drug-related problems with an incidence rate of 298" /><sentence text="48 per 1000 patient medical intensive care unit-day were identified" /><sentence text=" Most common drug-related problems were drug-drug interaction (48" /><sentence text="7%) followed by guideline nonconformity (15" /><sentence text="5%), inappropriate drug form (11" /><sentence text="9%), and contraindication (9" /><sentence text="6%)" /><sentence text=" Approximately 27% of drug-related problems induced preventable harm, which included temporary harm (19" /><sentence text="8%), permanent harm (5" /><sentence text="8%), and death (0" /><sentence text="8%)" /><sentence text=" The incidence rate of preventable harm was found to be 78" /><sentence text="78 per 1000 patient medical intensive care unit-day" /><sentence text=" Nonsteroidal anti-inflammatory drugs were the most common medications involved in drug-drug interaction, guideline nonconformity, and contraindication which led to gastrointestinal bleeding (24%) and worsening of renal function (11" /><sentence text="5%)" /><sentence text="" /><sentence text="Drug-related problems occurred commonly in critically ill patients with decompensated liver cirrhosis and induced preventable harm which jeopardized the safety of these vulnerable patients" /><sentence text=" Clinical pharmacist's intervention is essential for identification of drug-related problems and related preventable harm among these patients" /><sentence text="" /></document>